CRL Long Put Strategy

CRL (Charles River Laboratories International, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2.

CRL (Charles River Laboratories International, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $10.39B, a beta of 1.45 versus the broader market, a 52-week range of 144.26-228.88, average daily share volume of 870K, a public-listing history dating back to 2000, approximately 19K full-time employees. These structural characteristics shape how CRL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.45 indicates CRL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on CRL?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current CRL snapshot

As of June 29, 2026, spot at $224.24, ATM IV 48.80%, IV rank 32.75%, expected move 13.99%. The long put on CRL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long put structure on CRL specifically: CRL IV at 48.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 13.99% (roughly $31.37 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRL expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRL should anchor to the underlying notional of $224.24 per share and to the trader's directional view on CRL stock.

CRL long put setup

The CRL long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRL near $224.24, the first option leg uses a $220.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRL chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRL shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$220.00$8.00

CRL long put risk and reward

Net Premium / Debit
-$800.00
Max Profit (per contract)
$21,199.00
Max Loss (per contract)
-$800.00
Breakeven(s)
$212.00
Risk / Reward Ratio
26.499

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

CRL long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on CRL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

CRL long put profit and loss curve at expiration with breakevens and current spot markedCRL long put payoff at expiration$0$5000$10000$15000$20000$100$200$300$400Underlying Price ($)P&L at Expiration ($)BE $212.00Spot $224.24
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$21,199.00
$49.59-77.9%+$16,241.04
$99.17-55.8%+$11,283.08
$148.75-33.7%+$6,325.12
$198.33-11.6%+$1,367.16
$247.91+10.6%-$800.00
$297.49+32.7%-$800.00
$347.07+54.8%-$800.00
$396.65+76.9%-$800.00
$446.23+99.0%-$800.00

When traders use long put on CRL

Long puts on CRL hedge an existing long CRL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CRL exposure being hedged.

CRL thesis for this long put

The market-implied 1-standard-deviation range for CRL extends from approximately $192.87 on the downside to $255.61 on the upside. A CRL long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long CRL position with one put per 100 shares held. Current CRL IV rank near 32.75% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on CRL should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CRL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRL-specific events.

CRL long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRL alongside the broader basket even when CRL-specific fundamentals are unchanged. Long-premium structures like a long put on CRL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CRL chain quotes before placing a trade.

Frequently asked questions

What is a long put on CRL?
A long put on CRL is the long put strategy applied to CRL (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With CRL stock trading near $224.24, the strikes shown on this page are snapped to the nearest listed CRL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CRL long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the CRL long put priced from the end-of-day chain at a 30-day expiry (ATM IV 48.80%), the computed maximum profit is $21,199.00 per contract and the computed maximum loss is -$800.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CRL long put?
The breakeven for the CRL long put priced on this page is roughly $212.00 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRL market-implied 1-standard-deviation expected move is approximately 13.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on CRL?
Long puts on CRL hedge an existing long CRL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CRL exposure being hedged.
How does current CRL implied volatility affect this long put?
CRL ATM IV is at 48.80% with IV rank near 32.75%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CRL analysis